Walgreen Co. Agrees To Pay Over $2.8 Million To Settle Allegations Of Overbilling Medicaid Programs
The national pharmacy allegedly submitted inflated usual and customary prices to the Massachusetts and Georgia Medicaid programs for generic medications
BOSTON – Walgreen Co. (Walgreens) has agreed to pay over $2.8 million to resolve allegations that it violated the federal, Massachusetts and Georgia False Claims Acts by submitting inflated prices for certain generic medications to the Massachusetts and Georgia Medicaid programs.
Action Details
- Date:March 27, 2025
- Agency:U.S. Attorney's Office, District of Massachusetts
-
Enforcement Types:
- Criminal and Civil Actions
.png){kind=logo}